Natural products serve as critical drugs or drug precursors with broad pharmaceutical application, including serving as the most effective antibiotics. The widespread and rapid evolution of antibiotic-resistance in pathogenic microbes makes the discovery of novel therapeutics to treat infectious diseases of urgent importance. Despite this critical need, small molecule discovery has decreased substantially in recent decades and the pipeline of new antibiotics is rapidly diminishing. The broad goals of this project are to discover novel antibiotics with high therapeutic potential by identify new natural products from insect associated Actinobacteria (aim 1), using next-generation sequencing technology and bioinformatics to help discover novel compounds from symbiotic microbes (aim 2), and evaluating the natural products discovered in SAI and SA2 for their therapeutic potential (aim 3). Through its direct integration with the multidisciplinary team in the center, the work proposed holds the promise to generate numerous new drug leads with therapeutic potential, result in a new paradigm in drug discovery, and, by translation, to impact the treatment of drug-resistant infectious diseases on a global scale.

Public Health Relevance

The emergence of antibiotic resistance in human pathogens represents a public health crisis. The goals of this project are to discover new antimicrobial drug leads from symbiotic Actinobacteria and to contribute to the development of genome-enabled approaches to drug discovery.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI109673-01
Application #
8642727
Study Section
Special Emphasis Panel ()
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$503,572
Indirect Cost
$130,789
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ruzzini, Antonio C; Clardy, Jon (2016) Gene Flow and Molecular Innovation in Bacteria. Curr Biol 26:R859-64
Zhang, Yan; Adnani, Navid; Braun, Doug R et al. (2016) Micromonohalimanes A and B: Antibacterial Halimane-Type Diterpenoids from a Marine Micromonospora Species. J Nat Prod 79:2968-2972
Zhang, Fan; Adnani, Navid; Vazquez-Rivera, Emmanuel et al. (2015) Application of 3D NMR for Structure Determination of Peptide Natural Products. J Org Chem 80:8713-9
Van Arnam, Ethan B; Ruzzini, Antonio C; Sit, Clarissa S et al. (2015) A Rebeccamycin Analog Provides Plasmid-Encoded Niche Defense. J Am Chem Soc 137:14272-4
Ramadhar, Timothy R; Zheng, Shao-Liang; Chen, Yu-Sheng et al. (2015) The crystalline sponge method: MOF terminal ligand effects. Chem Commun (Camb) 51:11252-5
Ramadhar, Timothy R; Zheng, Shao Liang; Chen, Yu Sheng et al. (2015) Analysis of rapidly synthesized guest-filled porous complexes with synchrotron radiation: practical guidelines for the crystalline sponge method. Acta Crystallogr A Found Adv 71:46-58
Sit, Clarissa S; Ruzzini, Antonio C; Van Arnam, Ethan B et al. (2015) Variable genetic architectures produce virtually identical molecules in bacterial symbionts of fungus-growing ants. Proc Natl Acad Sci U S A 112:13150-4
Wyche, Thomas P; Piotrowski, Jeff S; Hou, Yanpeng et al. (2014) Forazoline A: marine-derived polyketide with antifungal in vivo efficacy. Angew Chem Int Ed Engl 53:11583-6